Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sharp Shalini
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   215,117    

Indirect Shares

   104,270      
Direct Value   $4,535,908    

Indirect Value

   $46,244      
Total Shares   319,387      
Total Value   $4,582,151      


Agenus Inc $36,061 Ultragenyx Pharmaceutical Inc $4,002,467 Nuvation Bio Ord Shs Class A $364,700 Neurocrine Biosciences Inc $132,679 Agenus Inc $36,061 Ultragenyx Pharmaceutical Inc $4,002,467 Nuvation Bio Ord Shs Class A $364,700 Neurocrine Biosciences Inc $132,679
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    6    

     Stock price went up :
    0   
    5    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   5.0   
     Percentage Gain/Loss :
     0.0%
 537.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agenus Inc AGEN Director 2013-01-30 81,311 2015-09-28 104,270    Premium*  
            Ultragenyx Pharmaceutical Inc RARE EVP, Finance 2020-10-14 97,812 0    Premium*  
            Nuvation Bio Ord Shs Class A NUVB Director 2021-02-10 35,000 2021-02-10 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2024-01-23 0 2021-03-26 0    Premium*  
            Neurocrine Biosciences Inc NBIX Director 2024-05-17 994 2024-05-17 0    Premium*  
* Premium Members only  

Records found :    130         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AGEN Agenus Inc CFO   •       –      –    2012-03-15 4 A $5.31 $25,817 D/D 4,862 69,252 0 -
AGEN Agenus Inc CFO   •       –      –    2012-04-26 4 A $6.43 $4,019 D/D 625 69,877 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-18 4 OE $6.86 $82,320 D/D 12,000 81,157 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-18 4/A OE $6.86 $82,320 D/D 12,000 81,126 0 -
NUVB Nuvation Bio Ord Shs Clas... Director   –       •      –    2021-02-10 4 A $10.00 $100,000 D/D 10,000 35,000 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-01-30 4 B $21.00 $94,500 D/D 4,500 84,255 2.74 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-11-20 4 AS $44.07 $176,281 D/D (4,000) 68,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-12-18 4 AS $44.82 $179,290 D/D (4,000) 64,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-10-20 4 AS $46.02 $184,080 D/D (4,000) 72,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-03-01 4 D $48.43 $19,227 D/D (397) 62,113 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-05-19 4 OE $48.43 $431,710 D/D 7,128 104,851 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-06-03 4 OE $48.43 $495,633 D/D 10,234 111,442 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-06-04 4 OE $48.43 $124,175 D/D 2,564 103,772 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-08-17 4 OE $48.43 $698,524 D/D 11,357 101,856 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2015-01-20 4 AS $51.24 $204,957 D/D (4,000) 60,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2015-02-18 4 AS $53.93 $215,935 D/D (4,000) 56,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-08-18 4 AS $53.97 $215,880 D/D (4,000) 80,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-06-01 4 D $54.93 $19,006 D/D (346) 67,246 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-09-18 4 AS $56.00 $224,000 D/D (4,000) 76,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-03-01 4 D $56.08 $130,386 D/D (2,325) 103,832 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2017-06-01 4 D $56.61 $21,285 D/D (376) 55,470 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2017-05-21 4 D $57.47 $23,793 D/D (414) 55,846 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-04-19 4 D $58.57 $14,525 D/D (248) 103,584 0 -
MRTX Mirati Therapeutics, Inc. Director   –       •      –    2023-12-29 4 A $58.75 $399,970 D/D 6,808 16,222 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-05-21 4 D $59.50 $22,670 D/D (381) 67,592 0 -
  130  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us